You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET review

Showing 1 - 25 of 9,717
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Non-invasive Dual-Pet Information in Subtype of Metastatic

Recruiting
  • Breast Cancer
  • biopsy or surgical pathology in metastases
  • 68Ga-HER2 affibody,18F-FDG, 18F-FES
  • Shanghai, Shanghai, China
    Shanghai Cancer Center Institutional Review Board
Apr 19, 2022

FDG PET MRI Management of Muscle Invasive Bladder Cancer

Completed
  • Bladder Cancer
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 8, 2021

    Prostatic Tumors Trial in Kingswood, Sydney, Murdoch (64Cu-SAR-bisPSMA)

    Active, not recruiting
    • Prostatic Neoplasms
    • Kingswood, New South Wales, Australia
    • +2 more
    Jul 27, 2022

    Follicular Lymphoma Trial in Duarte, Irvine (procedure, other, biological, drug)

    Not yet recruiting
    • Follicular Lymphoma
    • Biospecimen Collection
    • +7 more
    • Duarte, California
    • +1 more
    Oct 27, 2023

    Neuroendocrine Tumors Trial in Australia (64Cu-SARTATE)

    Recruiting
    • Neuroendocrine Tumors
    • Kingswood, New South Wales, Australia
    • +3 more
    May 17, 2022

    Score With PET/CT for Anal Squamous Cell Cancer

    Recruiting
    • Anal Squamous Cell Carcinoma
    • +9 more
    • Computed Tomography
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 7, 2022

    Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8

    Not yet recruiting
    • Stage II Nasopharyngeal Carcinoma AJCC v8
    • +2 more
    • Biopsy
    • +16 more
    • (no location specified)
    Oct 7, 2023

    Contribution of PET/MRI in Locally Advanced Cervical Cancer

    Not yet recruiting
    • Cervical Cancer
    • 18-FDG PET-MRI
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Oct 12, 2023

    Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • (no location specified)
    Jun 12, 2023

    Marginal Zone Lymphoma and Its Prognostic Role

    Recruiting
    • Marginal Zone Lymphoma
      • Dijon, France
      • +22 more
      Jan 17, 2023

      Prostate Cancer Trial in Montreal (18F-DCFPyL PET/CT)

      Enrolling by invitation
      • Prostate Cancer
      • 18F-DCFPyL PET/CT
      • Montreal, Quebec, Canada
        Jewish General Hospital
      May 3, 2022

      Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Carcinoma Trial in

      Not yet recruiting
      • Prostate Cancer
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Oct 19, 2023

      Role of FDG PET/CT in Patients With Metastasis of Unknown Origin

      Not yet recruiting
      • Metastasis
      • PET/CT
      • (no location specified)
      Sep 26, 2023

      Prostate Cancer, Prostatic Tumors Trial (64Cu-SAR-bisPSMA)

      Not yet recruiting
      • Prostate Cancer
      • Prostatic Neoplasms
      • (no location specified)
      Sep 21, 2023

      Aldosterone-Producing Adenoma Trial (CXCR4)

      Not yet recruiting
      • Aldosterone-Producing Adenoma
      • CXCR4
      • (no location specified)
      Apr 20, 2023

      Role of PET/CT in Peritoneal Deposits Assessment

      Not yet recruiting
      • Peritoneal Metastases
      • PET/CT
      • (no location specified)
      Nov 14, 2023

      Cancer Trial in Saint Louis (Augmented Whole-body Scanning via Magnifying PET, FDG-PET/CT, 18F- fluorodeoxyglucose)

      Not yet recruiting
      • Cancer
      • Augmented Whole-body Scanning via Magnifying PET
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 18, 2022

      Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

      Not yet recruiting
      • Anatomic Stage II Breast Cancer AJCC v8
      • +3 more
      • (no location specified)
      Jan 24, 2023

      18F-PFPN PET Imaging in Patients With Malignant Melanoma

      Recruiting
      • Melanoma
      • Wuhan, Hubei, China
        China, Hubei Province
      Dec 2, 2022

      Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)

      Not yet recruiting
      • Prostate Cancer
      • 18F-PSMA-1007 PET/CT based on diagnostic model
      • Hefei, Anhui, China
        The First Affiliated Hospital of USTC
      Dec 6, 2022

      Hepatocellular Carcinoma Trial (Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI
      • (no location specified)
      Jan 8, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023

      The Role of 18F-FDG-PET for Staging and Prognostication

      Recruiting
      • Mantle Cell Lymphoma
        • Reggio Calabria, Calabria, Italy
        • +30 more
        Dec 5, 2022